Table 2 List of differentially expressed proteins from discovery phase analysis.

From: Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway

Proteins

1st set (113:117)

2nd set (114:118)

3rd set (115:119)

4th set (114:116)

5th set (115:117)

Actin, Cytoplasmic 2

1.6169

0.9357

1.4223

1.0331

2.4749

Adiponectin

0.683

1.2263

0.9485

0.7327

0.5968

Alpha-1-acid glycoprotein 2

0.7813

0.9165

0.5037

0.948

0.6942

AMBP protein

1.1621

1.3553

1.6125

1.532

0.7091

Apolipoprotein A-I

0.6278

1.0048

0.3461

0.457

0.9389

Apolipoprotein A-IV

0.7265

0.8253

0.6901

1.001

0.7471

Apolipoprotein B-100

0.7909

0.8079

0.7438

0.787

0.8872

Apolipoprotein C-I

0.7838

0.486

0.4974

0.2886

0.9913

Apolipoprotein C-II

1.5611

0.73

0.5236

0.3934

1.2617

Apolipoprotein L1

0.9343

0.7858

1.1346

0.6109

0.7831

Dermcidin

1.7836

1.4488

4.6536

1.1599

2.0635

Fibrinogen gamma chain

0.7686

1.1267

1.4741

1.4227

1.2637

Glutathione peroxidase 3

0.7084

1.2212

0.4706

0.7414

1.0727

Peroxiredoxin-2

1.3775

0.8013

2.1358

0.9135

1.2761

Pregnancy zone protein

1.2713

0.9843

1.2544

1.9943

1.5681

Serum amyloid P-component

0.6806

1.0889

0.3114

0.3759

0.7074

Thymosin beta-4

2.2765

1.5369

0.8007

2.4334

4.0036

Vitronectin

0.9495

1.4318

1.0016

1.2879

1.363

Back to article page